The Opti-GAIN study from Complement Therapeutics is assessing the safety, tolerability, and preliminary efficacy in GA secondary to age-related macular degeneration (AMD) of CTx001. A first-in-human ...

First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...

First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

There is a lot of strategy that goes into the NFL Draft. Most mock drafts only cover the first round, but there are several considerations when making that initial selection. For example, if a team ...

They play positions of perceived need, the addressing of which is always an objective in veteran free agency, but what really resonates this year is the new additions play like Steelers. Wide receiver ...

After Purdue won four games in four days to win the Big Ten Tournament, it quickly will pivot to prepare for the NCAA Tournament. The two-seed Boilermakers learned their fate shortly after downing ...

NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- Vicarius today announced the launch of vIntelligence, a new product that introduces agentic intelligence and continuous validation to the company's ...

The Metropolitan Police Department’s executive assistant chief for patrol operations, Andre Wright, had his police powers revoked, News4 has learned. Wright was asked for his gun and badge on Thursday ...

SILVERSTONE, England -- Cadillac is naming its first Formula One car in honor of 1978 champion Mario Andretti, who calls it the “ultimate compliment” ahead of the team’s inaugural race next week at ...